Company Filing History:
Years Active: 2024
Title: Nadia Litterman: Innovator in ALS Treatment
Introduction
Nadia Litterman is a prominent inventor based in Los Altos, CA. She has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). Her innovative approach has garnered attention in the scientific community.
Latest Patents
Nadia holds a patent for a method titled "Synergistic combination therapy for treating ALS." This patent discloses methods for inhibiting the progression of ALS in humans. The methods utilize a synergistic combination of methyl-phenyl-pyrazoline-one and deuterated arachidonic acid or a prodrug thereof, such as 11,11-D2-linoleic acid or an ester thereof. This groundbreaking work has the potential to change the landscape of ALS treatment.
Career Highlights
Nadia is currently associated with Biojiva LLC, where she continues to develop her innovative ideas. Her work focuses on creating effective therapies that can improve the quality of life for individuals suffering from ALS. With her dedication and expertise, she is paving the way for future advancements in this critical area of healthcare.
Collaborations
Nadia collaborates with notable professionals in her field, including Peter Milner and Mark Midei. These partnerships enhance her research and contribute to the development of new therapeutic strategies.
Conclusion
Nadia Litterman is a trailblazer in the fight against ALS, with her innovative patent and collaborative efforts. Her work exemplifies the impact of dedicated inventors in advancing medical science and improving patient outcomes.